Trade Summary

3 months ago, Sun Nelson, serving as CFO at Aardvark Therapeutics, Inc. (AARD), purchased 6,000 shares at $8.07 per share, for a total transaction value of $48,440.00. Following this transaction, Sun Nelson now holds 105,484 shares of AARD.

This purchase represents a 6.00% increase in Sun Nelson's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, September 9, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, September 10, 2025, 1 day after the trade was made.

Aardvark Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.